Comparative pharmacokinetics of ropivacaine and bupivacaine in nonpregnant and pregnant ewes

Anesthesia and Analgesia

Volumn 85, Issue 1, 1997, Pages 87-93

  Santos, Alan C ^a,b,e   Richard Arthur, G ^c   Lehning, Ellen J ^a   Finster, Mieczyslaw ^d  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Coll Phys Surgs of Columbia Univ ^*  (United States)

^e North Central Bronx Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; ROPIVACAINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; OBSTETRIC ANESTHESIA; PRIORITY JOURNAL; SHEEP;

AMIDES; ANESTHETICS, LOCAL; ANIMALS; BLOOD PROTEINS; BUPIVACAINE; FEMALE; PREGNANCY; PREGNANCY, ANIMAL; PROTEIN BINDING; SHEEP;

EID: 0343036273     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199707000-00016     Document Type: Article

References (27)

1. Pihlajamäki K, Kanto J, Lindberg R, et al. Extradural administration of bupivacaine: pharmacokinetics and metabolism in pregnant and non-pregnant women. Br J Anaesth 1990;64: 556-62.
2. Santos AC, Pedersen H, Sallusto JA, et al. Pharmacokinetics of ropivacaine in nonpregnant and pregnant ewes. Anesth Analg 1990;70:262-6.
3. Santos AC, Arthur GR, Wlody D, et al. Comparative systemic toxicity of ropivacaine and bupivacaine in nonpregnant and pregnant sheep. Anesthesiology 1995;82:734-40.
4. Gill JL. Design and analysis of experiments in the animal and medical sciences. Vol. 2. Ames, IA: Iowa State University Press, 1978:301.
5. Brown JE, Kitchell BB, Bjornsson TD, Shand DG. The artifactual nature of heparin-induced drug protein-binding alterations. Clin Pharmacol Ther 1981;30:636-43.
6. Ridd MJ, Brown KF, Moore RG, Nation RL. Drug plasma binding and non-esterified fatty acids: methodologic considerations. Int J Pharmac 1982;11:11-20.
7. Arthur GR, Denson DD, Coyle DE. Effect of sodium thiopental on the serum protein binding of bupivacaine. Reg Anesth 1984; 9:171-4.
8. Nancarrow C, Runciman WB, Mather LE, et al. The influence of acidosis on the distribution of lidocaine and bupivacaine into the myocardium and brain of the sheep. Anesth Analg 1987;66: 925-35.
9. Gibaldi M, Perrier D. Pharmacokinetics. New York: Marcel Dekker, 1975:281-92.
10. Gibaldi M, Perrier D. Pharmacokinetics. New York: Marcel Dekker, 1975:55.
11. Loo JCK, Riegelman S. Assessment of pharmacokinetic constants from postinfusion blood curves obtained after i.v. infusion. J Pharm Sci 1970;59:53-5.
12. Nelder JA, Mead R. A simplex method for function minimization. Comput J 1965;7:308-13.
13. Ottaway JH. Normalization in the fitting of data by iterative methods: application to tracer kinetics and enzyme kinetics. Biochem J 1973;134:729-36.
14. Bloedow DC, Ralston DH, Hargrove JC. Lidocaine pharmacokinetics in pregnant and nonpregnant sheep. J Pharm Sci 1980; 69:32-7.
15. Santos AC, Pedersen H, Morishima HO, et al. Pharmacokinetics of lidocaine in nonpregnant and pregnant ewes. Anesth Analg 1988;67:1154-8.
16. 1-acid glycoprotein in mother and newborn infant. Clin Pharmacol Ther 1981;29:522-6.
17. Weiner M, Siddiqui AA, Shahani RT, Dayton PG. Effect of steroids on disposition of oxyphenbutazone in man. Proc Soc Exp Biol Med 1967;124:1170-3.
18. Caritis SN, Lin LS, Venkataramanan R, Wong LK. Effect of pregnancy on ritodrine pharmacokinetics. Am J Obstet Gynecol 1988;159:328-32.
19. Davis M, Simmons CJ, Dordoni B, et al. Induction of hepatic enzymes during normal human pregnancy. J Obstet Gynaecol Br Common 1973;80:690-4.
20. Harrison LI, Gibaldi M. Influence of cholestasis on drug elimination: pharmacokinetics. J Pharm Sci 1976;65:1346-8.
21. Aldridge A, Bailey J, Neims AH. The disposition of caffeine during and after pregnancy. Semin Perinatol 1981;5:310-4.
22. Rosenberg PH, Kyttä J, Alila A. Absorption of bupivacaine, etidocaine, lignocaine and ropivacaine into n-heptane, rat sciatic nerve, and human extradural and subcutaneous fat. Br J Anaesth 1986;58:310-4.
23. Datta S, Camann W, Bader A, VanderBurgh L. Clinical effects and maternal and fetal plasma concentrations of epidural ropivacaine versus bupivacaine for Cesarean section. Anesthesiology 1995;82:1346-52.
24. Dahl JB, Simonsen L, Mogensen T, et al. The effect of 0.5% ropivacaine on epidural blood flow. Acta Anaesthesiol Scand 1990;34:308-10.
25. Denson DD, Coyle DE, Thompson GA, et al. Bupivacaine protein binding in the term parturient: effects of lactic acidosis. Clin Pharmacol Ther 1984;35:702-9.
26. McNamara PJ, Slaughter RL, Pieper JA, et al. Factors influencing serum protein binding of lidocaine in humans. Anesth Analg 1981;60:395-400.
27. Rutten AJ, Mather LE, Plummer JL, Henning EC. Postoperative course of plasma protein binding of lignocaine, ropivacaine and bupivacaine in sheep. J Pharm Pharmacol 1992;44:355-8.